• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AZIYO BIOLOGICS, INC. PROXICOR FOR CARDIAC TISSUE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AZIYO BIOLOGICS, INC. PROXICOR FOR CARDIAC TISSUE REPAIR Back to Search Results
Model Number CMCV-120-404
Device Problems Break (1069); Peeled/Delaminated (1454); Material Separation (1562)
Patient Problems Death (1802); Aortic Dissection (2491)
Event Date 12/24/2019
Event Type  Death  
Manufacturer Narrative
Manufacturing review of the device history record for the reported lot shows that all units were quality released on 11/27/2019 having met all internal qc acceptance requirements.There were no non-conformances associated with the manufacturing lot during production and final packaging.The oem supplier reviewed the sub-lots associated with the reported lot and confirmed that "all devices met specification." the instructions for use provided with the proxicor for cardiac tissue repair product (art-20700b), under the section 'potential complications', states in part: "the following complications are possible.If any of these conditions occur, a medical professional should evaluate if the removal of the proxicor is required: patch dehiscence or rupture." it can be noted that the reported saline soak time prior to use was 10 minutes.The ifu recommends soak time of 1-2 minutes.The exact cause of the reported event cannot be conclusively determined.
 
Event Description
On (b)(6) 2019 a newborn female patient underwent surgery for a diagnosis of aortic arch hypoplasia and ivc.Aziyo proxicor for cardiac tissue repair (ctr) was used.Once the patient was sutured, hemodynamic deterioration occured.Arterial line (umbilical artery cannulation) checked; malfunction is ruled out.An ecography checked the position of the ctr patch.Since the hemodynamic compromise was maintained, the patient was reconnected to extracorporeal circulation.Once again exposing the operative field, the doctor visualized that the ctr patch presents what he described as a "dissection" of the same.Ctr removed and replaced with a baxter peri-guard pericardium patch.Patient subsequently taken to neonatal icu where, after a couple of hours, patient expired.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROXICOR FOR CARDIAC TISSUE REPAIR
Type of Device
PROXICOR FOR CARDIAC TISSUE REPAIR
Manufacturer (Section D)
AZIYO BIOLOGICS, INC.
1100 old ellis road
ste 1200
roswell GA 30076
Manufacturer (Section G)
AZIYO BIOLOGICS, INC.
1100 old ellis road
ste 1200
roswell GA 30076
Manufacturer Contact
andrew green
1100 old ellis road
ste 1200
roswell, GA 30076
MDR Report Key9664341
MDR Text Key177561445
Report Number3005619880-2020-00001
Device Sequence Number1
Product Code DXZ
Combination Product (y/n)N
Reporter Country CodeCI
PMA/PMN Number
K063349
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign
Reporter Occupation Other
Type of Report Initial
Report Date 02/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/04/2020
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2021
Device Model NumberCMCV-120-404
Device Lot NumberM19M1538
Was Device Available for Evaluation? No
Date Manufacturer Received01/06/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/27/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age1 MO
Patient Weight2
-
-